Amgen shares top $100 as fears fade over biosimilars
By Stephen Nellis / Friday, April 5th, 2013 / Comments Off on Amgen shares top $100 as fears fade over biosimilars
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
NEXT ARTICLE →
Up in the air: When it makes sense to take your small business into the cloud
← PREVIOUS ARTICLE
Green Coast 2013: How the region is leading the way in energy efficiency
Related Articles
Popular articles
- None Found
Sponsored content:
SHIPS SLOW TO PROTECT WHALES, BLUE SKIES
-
Sign up for email news
Get the Business Times in your inbox. Sign up for breaking news alerts, our weekly briefing, and more.Sign upFor Email Marketing you can trust.2015-2016 Giving Guide
Check out our 2015 Giving Guide special issue